2024Äê1ÔÂ9ÈÕ£¬ÖйúÉϺ£¡ª¡ªng28ÄϹ¬Ðû²¼£¬°¢¶û´Äº£Ä¬²¡£¨ÏÂÎļò³Æ£ºAD£©Á¢ÒìÖÎÁÆÒ©ÎïÀÖÒâ±£?£¨ÂØ¿¨Ä¹£©»ñ¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾Ö£¨NMPA£©Åú×¼Õýʽ½øÈëÖйú£¬ÓÃÓÚÖÎÁÆÓÉ°¢¶û´Äº£Ä¬²¡ÒýÆðµÄÇá¶ÈÈÏÖªÕÏ°ºÍ°¢¶û´Äº£Ä¬²¡Çá¶È³Õ´ô¡£×÷ΪȫÇòÊ׸öÕë¶ÔAD²¡ÒòµÄÍ»ÆÆÐÔ°ÐÏòÒ©ÎÀÖÒâ±£?µÄ»ñÅú½«ÒýÁìADÖÎÁÆ¿çÈë¡°¶ÔÒòÖÎÁÆ¡±ÐÂʱ´ú£¬ÎªÖйúAD»¼ÕßÌṩ¸üÓÅÖÎÁÆÑ¡Ôñ¡£
ÀÖÒâ±£?£¨ÂØ¿¨Ä¹£©ÖØ°õ»ñÅú
ÖйúǧÍò°¢¶û´Äº£Ä¬²¡»¼ÕßÖÎÁÆÐèÇóؽ´ýÂú×ã
ADÊÇÒ»ÖÖ½øÐÐÐÔ¡¢²»¿ÉÄæµÄÉñ¾ÍËÐÐÐÔÄÔ¼²²¡£¬»áµ¼Ö»¼ÕßÖÇÁ¦ÕÏ°¡¢¾«ÉñÒì³£¡¢Éç»áÓëÉú»î¹¦Ð§É¥Ê§[1]£¬ÑÏÖØÓ°Ï컼ÕßµÄÈÏÖªÄÜÁ¦ºÍÕý³£Éú»î¡£
Á÷Ðв¡Ñ§ÊÓ²ìÖ¸³öÎÒ¹ú60ËêÒÔÉÏÈË¿ÚÖÐÓгմô»¼ÕßÔ¼1507Íò£¬ÆäÖÐADÔ¼983ÍòÈË£¬ÁíÓÐMCIÔ¼3877ÍòÈË[2]£¬ÇÒADÒѳÉΪÎÒ¹úµÚÎå´óÖÂËÀ¼²²¡£¬£¬Ã¿Äê´øÀ´¸ß´ï1677ÒÚÃÀÔªµÄ¼²²¡Ö§³ö[3]£¬¸ø¹«¹²ÎÀÉúϵͳ´øÀ´Á˼«Öصľ¼ÃºÍÉç»áµ£¸º¡£
½üǧÍòÁ¿¼¶µÄº£ÄÚ»¼Õߺã¾ÃÒÔÀ´´¦ÓÚȱҽÉÙÒ©µÄÀ§¾³ÖУ¬ÓÉÓÚAD·¢²¡»úÖÆÅÓ´óÇÒÁÙ´²ÊÔÑéÉóºË³ÌÐòºÜÊÇÑÏ¿Á£¬ADÐÂÒ©Ñз¢ÓÐ×ÅÒµ½ç¹«ÈÏ99.6%µÄ×î¸ßʧ°ÜÂÊ[4]£¬±»³ÆΪҩÎïÑз¢¡°ËÀÍö¹È¡±¡£Ä¿Ç°ÓÃÓÚÖÎÁÆADµÄÒ©Îï»ù±¾ÉÏÖ»ÄܸÄÉƼ²²¡µÄÖ¢×´£¬¶ø²»¿ÉÓÐЧÑÓ»º¼²²¡½ø³Ì¡£
?
ËÄÊ®ÄêÉî¸ûר²¡ÁìÓò ÀÖÒâ±£?ΪÔçÆÚ»¼Õß´øÀ´ÑÓ»º²¡ÇéÐÂÏ£Íû
ng28ÄϹ¬Éî¸ûADÁìÓòËÄÊ®ÓàÔØ£¬Ð¯ÊÖÈ«Çò¿Æѧ¼Ò»ý¼«¹¥¿ËÖÎÁÆÕÏ°£¬ÖÕÓÚÀÖ³ÉÓÀ´ÀÖÒâ±£?µÄÎÊÊÀ¡£ÏȽøµÄÖÎÁÆ»úÖÆʹ֮³ÉΪ¶þÊ®ÄêÀ´Ê׿î»ñÃÀ¹úFDAÍêÈ«Åú×¼µÄ¿¹A¦Â¼²²¡ÐÞÊÎÒ©Îï¡£
¸£½¨Ò½¿Æ´óѧÁ¥ÊôкÍÒ½ÔºÉñ¾ÄÚ¿ÆÖ÷ÈÎҽʦ³ÂÏþ´º½ÌÊÚÌåÏÖ£º¡°ÂØ¿¨Ä¹Í¨¹ýÖ±½Ó¸ÉÔ¤°¢¶û´Äº£Ä¬²¡Ö²¡ÔªÐ×£¬Õë¶Ô²¡ÀíÂÑ°×µÄÒì³£¾Û¼¯½øÐе÷Àí¡£ÔÚÐÂÓ¢¸ñÀ¼ÔÓÖ¾ÉÏÐû²¼µÄÂØ¿¨Ä¹ÈýÆÚÈ«Çò¶àÖÐÐÄÁÙ´²Ñо¿Êý¾ÝÏÔʾ£¬¸ÃÒ©ÌåÏÖ³öÏÔÖøµÄÁÆЧºÍÁ¼ºÃµÄÄþ¾²ÐÔ£¬ÓÃÒ©3¸öÔ¼´´ó¸±½µµÍA¦Â¸ººÉ[5],[6]£¬18¸öÔÂÓÐЧ»º½â¼²²¡½øÕ¹27%6,[7]£»60%¸üÔçÆÚ»¼ÕßʵÏÖ²¡³ÌÄæת[8]£¬×ÊÖúÔçÆÚAD»¼Õ߸ÄÉÆÈÏÖªÕÏ°£¬Î¬³Ö¸ü¾ÃµÄ¶ÀÁ¢Éú»îʱ¼ä£¬´Ó¶ø¼õÉÙ¼ÒÍ¥ÓëÉç»á¾¼Ãµ£¸º[9]£¬Ò²ÎªÁÙ´²Ò½Éú·¿ªÁË¡®¶ÔÒòÖÎÁÆ¡¯µÄÈ«ÐÂ˼·¡£¡°
ÃñÖÚ¶Ô°¢¶û´Äº£Ä¬²¡ÈÏ֪ȱ·¦£¬ÍùÍùêÝÎóÖÎÁÆʱ»ú
ÓëÖйú¸ß·¢ÇÒÑÏÖصÄAD¼²²¡ÏÖ×´ÐγÉÏÊÃ÷±ÈÕÕµÄÊÇÃñÖÚ¶Ô¼²²¡µÄÈÏÖªÆÕ±éµÍÏ£¬¶ÔADÔçÆÚÖ¢×´ÌåÏÖȱ·¦Åжϣ¬¾³£½«¡°ÀÏÄê³Õ´ô¡±ÎóÈÏΪ¡°ÀϺýÍ¿¡±£»¶ÔÄÔ¼¹Òº´©´ÌµÈ¿ÆѧÕï¶ÏÒªÁìÒ²²»·¦µÖ´¥ÇéÐ÷£¬µ¼ÖÂÎÒ¹ú»¼ÕßÔÚAD¼²²¡ÔçÆÚÕï¶ÏºÍÔçÆÚ¸ÉÔ¤ÉϵÄÐж¯Á¦ÆÕ±éȱ·¦£¬ÍùÍù´í¹ý×î¼Ñ¼²²¡¸ÉÔ¤ ¡°»Æ½ðÆÚ¡±£¨Çá¶ÈÈÏÖªÕÏ°½×¶Î£¬¼´Å¼¶ûÍü¼ÇһЩÊÂÇéµÄϸ½Ú£¬µ«²»Ó°ÏìÉú»î£©¡£
³ÂÏþ´º½ÌÊÚÖ¸³ö£º¡°ÁÙ´²Ó¦ÓÃÂØ¿¨Ä¹ÐèÒªÕÆÎÕÔçÆÚADÕâ¸öÒªº¦µÄ»Æ½ð´°¿ÚÆÚ£¬Ö»ÓÐÕâÑù²ÅÓпÉÄÜÈøü¶àµÄAD»¼Õß´ÓÖÎÁÆÖлñÒæ¡£Ïà½ÏÓÚÒÔÍùµÄÅųý·¨£¬ÏÖÐеÄÉúÎï±ê¼ÇÎïÕï¶ÏÌåϵ£¬ÈçÁÙ´²Í¨¹ýPET-CT¡¢ÄÔ¼¹Òº¼ì²é¡¢ÍâÖÜѪ¼ì²âÈýÖÖ¼ì²âÊֶξßÓÐÏÔÖøµÄÓÅÊÆ£¬Ò»ÊÇÌá¸ßÁËÕï¶ÏµÄÁéÃô¶ÈÓëÌØÒì¶È£¬¶þÊÇʹADµÄÔçÆÚÕï¶Ï³ÉΪ¿ÉÄÜ¡£Ï£ÍûÃñÖÚ¸ü¶à¹Ø×¢°¢¶û´Äº£Ä¬²¡£¬×öµ½Ôçɸ²é¡¢Ôç·¢Ã÷¡¢ÔçÖÎÁÆ£¬ÕùÈ¡¸ßÆ·ÖʵÄÉú»îºÍÅã°é¡£¡±
°¢¶û´Äº£Ä¬²¡Ê®´óÖ¢×´
¿ÉÇ°ÍùÒø·¢Í¨Ð¡³ÌÐò£¬Íê³É3·ÖÖÓÄÔ½¡¿µ×Բ⣬
²¢Á˽⡰ӰÏóµØͼ¡°µÈADÏà¹ØÐÅÏ¢
ng28ÄϹ¬Ð¯ÊÖÉç»áÁ¦Á¿£¬Çý¶¯AD¼²²¡ÕïÁƹؿÚÇ°ÒÆ£¬ÓÅ»¯»Æ½ð¸ÉÔ¤ÆÚÓÃÒ©¿É¼°ÐÔ
¡°¼²²¡ÕïÁƹؿÚÇ°ÒƺÍÐÂÒ©¿É¼°ÐÔÊÇng28ÄϹ¬¾Û½¹µÄÖØÐÄ£¬¡±ng28ÄϹ¬È«Çò¸ß¼¶¸±×ܲã¬ng28ÄϹ¬Öйú×ܲ÷ëÑÞ»ÔŮʿÌåÏÖ£¬¡°Ëæ×ÅÀÖÒâ±£?»ñÅú£¬ng28ÄϹ¬½«Ð¯ÊÖÉç»á¸÷½çÁ¦Á¿£¬½¨Á¢ADÔçÕïÔçÖοÆÆÕÌåϵ£¬Ìá¸ßÈ«Éç»á¶ÔAD¼²²¡µÄÈÏÖª£¬Í¬Ê±Ò²½«»ý¼«Íƶ¯Á¢ÒìÖ§¸¶µÈ»¼Õ߹ذ®ÏîÄ¿£¬ÍêÉƶàÌõÀí°ü¹ÜÌåϵ£¬»Ý¼°¸ü¶à»¼Õß¼ÒÍ¥¡£ÌåÌùÈËÀཡ¿µ£¨human?health?care£©ÊÇng28ÄϹ¬¼á³ÖÎȶ¨µÄʹÃü¡£ÎÒÃÇÁ¦Çó±ÈAD»¼Õß¼°Æä¼ÒÍ¥¸üÁ˽âËûÃÇÕæʵµÄÐèÇó£¬ÔÚÊØ»¤Ó°ÏóºÍÇ×Çéî¿°íµÄÃÅ·ÉÏһ·Åã°é£¬ÎªËûÃÇ´øÈ¥¸ü¶à¸£ìí¡£¡±
ng28ÄϹ¬¼ò½é
ng28ÄϹ¬ÔÚÖйúÄÔ½¡¿µÁìÓò¸û×÷¶þÊ®¶àÄ꣬һֱ³Ð¼ÌÌåÌùÈËÀཡ¿µ£¨human health care£©µÄÆóҵʹÃü£¬Ê¼ÖÕÖ§³Ö¡°ÄÔ½¡¿µÐж¯¡±ËùÌá³öµÄ¸÷ÏîÖ÷ÕźͲ½·¥£¬²¢»ý¼«¼ÓÈëAD¿ÆÆÕÊÖ²á¿ÆÆÕÐû´«¡£¹Ø×¢Ó°Ï󽡿µ£¬ÌᳫÔçɸ¡¢ÔçÕï¡¢ÔçÖΣ¬²»¿ÉÊǹ«Ë¾µÄÔðÈΣ¬Ò²ÊÇ×÷ΪÉç»á³ÉÔ±µÄÔðÈΡ£
[1] Öйú³Õ´ôÓëÈÏÖªÕÏ°Ö¸ÄÏд×÷×é,ÖйúҽʦлáÉñ¾ÄÚ¿Æҽʦ·Ö»áÈÏÖªÕÏ°¼²²¡×¨ÒµÎ¯Ô±»á.2018Öйú³Õ´ôÓëÈÏÖªÕÏ°ÕïÖÎÖ¸ÄÏ(Ò»):³Õ´ô¼°Æä·ÖÀàÕï¶Ï±ê×¼.ÖлªÒ½Ñ§ÔÓÖ¾.2018;98(13):965-970
[2] Jia L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross?sectional study. Lancet Public Health. 2020;5(12): e661?e671
[3] Jia J, et al.Alzheimers Dement. 2018 Apr;14(4):483 491.
[4] Cummings J. Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes. Clin Transl Sci. 2018;11(2):147-152
[5] Michael C. Irizarry, AAIC 2023 presentation¡°Lecanemab : Amyloid Reduction and Evidence of Downstream Biomarker Modification¡±.
[6] lecanemab-irmb injection (LEQEMBI?), FDA label£¨ 202307£©
[7] van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in Early Alzheimer’s Disease[J]. N Engl J Med,? 2023, 388(1):9-21
[8] Keith Johnson. CTAD 2023 presentation¡°Biomarker Assessments from Clarity AD: Downstream Implications of Targeting Protofibrils and Tau as a Predictive Biomarker¡±.